| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $205.1M | — | +35.9% |
| Cost of Revenue | $126.7M | — | +33.8% |
| Gross Profit | $78.5M | — | +39.3% |
| R&D Expense | $11.4M | — | +2.3% |
| SG&A Expense | $20.7M | — | +21.3% |
| Operating Income | -$5.2M | — | +66.1% |
| Interest Expense | $1.3M | — | +5.9% |
| Pre-tax Income | -$5.0M | — | +66.8% |
| Income Tax | $248K | — | — |
| Net Income | -$5.3M | — | +65.1% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $21.0M | +40.3% | +35.7% |
| Short-term Investments | $202.9M | -0.6% | -6.0% |
| Accounts Receivable | $119.7M | +23.0% | +40.0% |
| Inventory | $3.6M | -8.1% | -10.7% |
| Current Assets | $364.1M | +8.8% | +8.8% |
| Total Assets | $740.3M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $14.6M | — | +496.2% |
| Investing Cash Flow | -$9.3M | — | -152.9% |
| Financing Cash Flow | $830K | — | +62.7% |
| +7.3% |
| Current Liabilities | $204.4M | +129.8% | +128.6% |
| Total Liabilities | $457.1M | +7.1% | +20.6% |
| Stockholders' Equity | $282.0M | +2.3% | -9.0% |